Skip to main content
Top

01-03-2016 | Gout | Article

A cross-sectional internet-based patient survey of the management strategies for gout

Journal: BMC Complementary and Alternative Medicine

Authors: Jasvinder A. Singh, Nipam Shah, N. Lawrence Edwards

Publisher: BioMed Central

Abstract

Background

Almost half of the patients with gout are not prescribed urate-lowering therapy (ULT) by their health care provider and >50 % use complementary and alternative therapies. Diet modification is popular among gout patients due to known associations of certain foods with gout flares. The interplay of the use of dietary supplements, diet modification, and ULT adherence in gout patients is not known. Despite the recent interest in diet and supplements, there are limited data on their use. Our objective was to assess ULT use and adherence and patient preference for non-pharmacological interventions by patients with gout, using a cross-sectional survey.

Methods

People who self-reported physician-diagnosed gout during their visit to a gout website (http://​gouteducation.​org) were invited to participate in a brief anonymous cross-sectional Internet survey between 08/11/2014 to 04/14/2015 about the management of their gout. The survey queried ULT prescription, ULT adherence, the use of non-pharmacological interventions (cherry extract, diet modification) and the likelihood of making a lifelong diet modification for gout management.

Results

A total of 499 respondents with a mean age 56.3 years were included; 74 % were males and 74 % were White. Of these, 57 % (285/499) participants were prescribed a ULT for gout, of whom 88 % (251/285) were currently taking ULT. Of those using ULT, 78 % (97/251) reported ULT adherence >80 %. Gender, race, and age were not significantly associated with the likelihood of receiving a ULT prescription or ULT adherence >80 %. Fifty-six percent of patients with gout preferred ULT as a lifelong treatment for gout, 24 % preferred cherry extract and 16 % preferred diet modification (4 % preferred none). Men had significantly lower odds of preferring ULT as the lifelong treatment choice for gout vs. other choices (p = 0.03). We found that 38.3 % participants were highly motivated to make a lifelong dietary modification to improve their gout (score of 9–10 on a 0–10 likelihood scale). Older age was significantly associated with high level of willingness to modify diet (p = 0.02).

Conclusion

We found that only 57 % of gout patients reported being prescribed ULT. 40 % of gout patients preferred non- pharmacological interventions such as cherry extract and diet modification for gout management. The latter finding requires further investigation.
Literature
1.
Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007–2008. Arthritis Rheum. 2011;63(10):3136–41. doi:10.​1002/​a4rt.​30520.
2.
Strand V, Khanna D, Singh JA, Forsythe A, Edwards NL. Improved health-related quality of life and physical function in patients with refractory chronic gout following treatment with pegloticase: evidence from phase III randomized controlled trials. J Rheumatol. 2012;39(7):1450–7. doi:10.​3899/​jrheum.​111375.CrossRefPubMed
3.
Scire CA, Manara M, Cimmino MA, Govoni M, Salaffi F, Punzi L, et al. Gout impacts on function and health-related quality of life beyond associated risk factors and medical conditions: results from the KING observational study of the Italian Society for Rheumatology (SIR). Arthritis Res Ther. 2013;15(5):R101. doi:10.​1186/​ar4281.CrossRefPubMedPubMedCentral
4.
Khanna PP, Nuki G, Bardin T, Tausche AK, Forsythe A, Goren A, et al. Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: Results from a cross-sectional survey. Health Qual Life Outcomes. 2012;10:117. doi:10.​1186/​1477-7525-10-117.CrossRefPubMedPubMedCentral
5.
Hirsch JD, Terkeltaub R, Khanna D, Singh J, Sarkin A, Shieh M, et al. Gout disease-specific quality of life and the association with gout characteristics. Patient Relat Outcome Meas. 2010;1:1–8.CrossRefPubMedCentral
6.
Singh JA, Strand V. Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans. Ann Rheum Dis. 2008;67(9):1310–6. doi:10.​1136/​ard.​2007.​081604.CrossRefPubMed
7.
Zhang W, Doherty M, Bardin T, Pascual E, Barskova V, Conaghan P, et al. EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2006;65(10):1312–24.CrossRefPubMedPubMedCentral
8.
Khanna D, Fitzgerald JD, Khanna PP, Bae S, Singh MK, Neogi T, et al. 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res. 2012;64(10):1431–46. doi:10.​1002/​acr.​21772.CrossRef
9.
Choi HK. A prescription for lifestyle change in patients with hyperuricemia and gout. Curr Opin Rheumatol. 2010;22(2):165–72. doi:10.​1097/​BOR.​0b013e328335ef38​.CrossRefPubMed
10.
Zhang Y, Neogi T, Chen C, Chaisson C, Hunter DJ, Choi HK. Cherry consumption and decreased risk of recurrent gout attacks. Arthritis Rheum. 2012;64(12):4004–11. doi:10.​1002/​art.​34677.CrossRefPubMedPubMedCentral
11.
Briesacher BA, Andrade SE, Fouayzi H, Chan KA. Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy. 2008;28(4):437–43. doi:10.​1592/​phco.​28.​4.​437.CrossRefPubMedPubMedCentral
12.
Singh JA, Bharat A, Edwards NL. An Internet Survey of Common Treatments Used by Patients With Gout Including Cherry Extract and Juice and Other Dietary Supplements (In press). Journal of Clinical Rheumatology. 2015.
13.
Sarawate CA, Brewer KK, Yang W, Patel PA, Schumacher HR, Saag KG, et al. Gout medication treatment patterns and adherence to standards of care from a managed care perspective. Mayo Clin Proc. 2006;81(7):925–34.CrossRefPubMed
14.
Singh JA, Hodges JS, Toscano JP, Asch SM. Quality of care for gout in the US needs improvement. Arthritis Rheum. 2007;57(5):822–9. doi:10.​1002/​art.​22767.CrossRefPubMedPubMedCentral
15.
Singh JA. Facilitators and barriers to adherence to urate-lowering therapy in African-Americans with gout: a qualitative study. Arthritis Res Ther. 2014;16(2):R82. doi:10.​1186/​ar4524.CrossRefPubMedPubMedCentral
16.
Harrold LR, Mazor KM, Peterson D, Naz N, Firneno C, Yood RA. Patients’ knowledge and beliefs concerning gout and its treatment: a population based study. BMC Musculoskelet Disord. 2012;13:180. doi:10.​1186/​1471-2474-13-180.CrossRefPubMedPubMedCentral
17.
Harrold LR, Mazor KM, Velten S, Ockene IS, Yood RA. Patients and providers view gout differently: a qualitative study. Chronic Illn. 2010;6(4):263–71. doi:10.​1177/​1742395310378761​.CrossRefPubMedPubMedCentral
18.
Singh JA. Research priorities in gout: the patient perspective. J Rheumatol. 2014;41(3):615–6. doi:10.​3899/​jrheum.​131258.CrossRefPubMedPubMedCentral
19.
Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Alcohol intake and risk of incident gout in men: a prospective study. Lancet. 2004;363(9417):1277–81.CrossRefPubMed
20.
Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med. 2004;350(11):1093–103.CrossRefPubMed
21.
Choi HK, Curhan G. Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. BMJ. 2008;336(7639):309–12. doi:10.​1136/​bmj.​39449.​819271.​BE.CrossRefPubMedPubMedCentral
22.
Choi HK, Gao X, Curhan G. Vitamin C intake and the risk of gout in men: a prospective study. Arch Intern Med. 2009;169(5):502–7. doi:10.​1001/​archinternmed.​2008.​606.CrossRefPubMedPubMedCentral
23.
Choi HK. Diet, alcohol, and gout: how do we advise patients given recent developments? Curr Rheumatol Rep. 2005;7(3):220–6.CrossRefPubMed
24.
MacFarlane LA, Kim SC. Gout: a review of nonmodifiable and modifiable risk factors. Rheum Dis Clin N Am. 2014;40(4):581–604. doi:10.​1016/​j.​rdc.​2014.​07.​002.CrossRef
25.
Harrold LR, Yood RA, Mikuls TR, Andrade SE, Davis J, Fuller J, et al. Sex differences in gout epidemiology: evaluation and treatment. Ann Rheum Dis. 2006;65(10):1368–72. doi:10.​1136/​ard.​2006.​051649.CrossRefPubMedPubMedCentral
26.
Riedel AA, Nelson M, Joseph-Ridge N, Wallace K, MacDonald P, Becker M. Compliance with allopurinol therapy among managed care enrollees with gout: a retrospective analysis of administrative claims. J Rheumatol. 2004;31(8):1575–81.PubMed
27.
Bailey RL, Gahche JJ, Lentino CV, Dwyer JT, Engel JS, Thomas PR, et al. Dietary supplement use in the United States, 2003–2006. J Nutr. 2011;141(2):261–6. doi:10.​3945/​jn.​110.​133025.CrossRefPubMedPubMedCentral
28.
Schlesinger N, Rabinowitz R, Schlesinger M. Pilot studies of cherry juice concentrate for gout flare prophylaxis. J Arthritis. 2012;1:1–5.CrossRef
29.
Andres M, Sivera F, Falzon L, Buchbinder R, Carmona L. Dietary supplements for chronic gout. Cochrane Database Syst Rev. 2014;10:CD010156. doi:10.​1002/​14651858.​CD010156.​pub2.PubMed
30.
Chaichian Y, Chohan S, Becker MA. Long-term management of gout: nonpharmacologic and pharmacologic therapies. Rheum Dis Clin North Am. 2014;40(2):357–74.
31.
Zhang Y, Chen C, Choi H, Chaisson C, Hunter D, Niu J, et al. Purine-rich foods intake and recurrent gout attacks. Ann Rheum Dis. 2012;71(9):1448–53. doi:10.​1136/​annrheumdis-2011-201215.CrossRefPubMedPubMedCentral
32.
Zhang Y, Woods R, Chaisson CE, Neogi T, Niu J, McAlindon TE, et al. Alcohol consumption as a trigger of recurrent gout attacks. Am J Med. 2006;119(9):800.e13–8.CrossRef
33.
Shulten P, Thomas J, Miller M, Smith M, Ahern M. The role of diet in the management of gout: a comparison of knowledge and attitudes to current evidence. J Hum Nutr Diet. 2009;22(1):3–11. doi:10.​1111/​j.​1365-277X.​2008.​00928.​x.CrossRefPubMed
34.
Singh JA. Challenges faced by patients in gout treatment: a qualitative study. J Clin Rheumatol. 2014;20(3):172–4. doi:10.​1097/​RHU.​0000000000000091​.PubMedPubMedCentral
35.
Nasser-Ghodsi N, Harrold LR. Overcoming adherence issues and other barriers to optimal care in gout. Curr Opin Rheumatol. 2015;27(2):134–8. doi:10.​1097/​BOR.​0000000000000141​.CrossRefPubMed
36.
Rees F, Jenkins W, Doherty M. Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study. Ann Rheum Dis. 2013;72(6):826–30. doi:10.​1136/​annrheumdis-2012-201676.CrossRefPubMed
37.
Spencer K, Carr A, Doherty M. Patient and provider barriers to effective management of gout in general practice: a qualitative study. Ann Rheum Dis. 2012;71(9):1490–5. doi:10.​1136/​annrheumdis-2011-200801.CrossRefPubMed